Earnings Insights
AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.
How to use these insights
Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.
IRIS Regtech Solutions Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Operating margins in the SupTech business currently run around 30%; SaaS business margins will improve once it achieves higher scale. Key concall takeaways…
19 Jul 2026
ICE Make Refrigeration Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
1000 crore revenue by FY’27-28, indicating strong growth ambitions. Key concall takeaways from ICE Make Refrigeration Ltd's Q2 FY26 earnings call — and how it…
19 Jul 2026
Abans Financial Services Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
30 crores from managing approximately $30 million in funds. Key concall takeaways from Abans Financial Services Ltd's Q4 FY25 earnings call — and how it ranks…
19 Jul 2026
Landmark Cars Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
The company has demonstrated capacity to rapidly and profitably grow when opportunities arise, with a 20% growth in calendar year 2025 vs. Key concall…
19 Jul 2026
Yasho Industries Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Revenue potential of INR 1,500 crores by FY '28 reflects the company's capacity after debottlenecking and long-term supply agreements. Key concall takeaways…
19 Jul 2026
Yasho Industries Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
Pakhajan plant utilization to reach 85%-90% by the last quarter of FY '26. Key concall takeaways from Yasho Industries Ltd's Q3 FY25 earnings call — and how it…
19 Jul 2026
Tara Chand Infralogistic Solutions Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
Growth drivers include ramp-up in key client operations like RINL, increased equipment utilization (currently 85%-89%), and strategic CAPEX expansion planned…
19 Jul 2026
Felix Industries Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Metal business potentially contributing 50 crores revenue in FY26-27 if discussions materialize. Key concall takeaways from Felix Industries Ltd's Q3 FY26…
19 Jul 2026
Solex Energy Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Solex Energy's current order book exceeds INR 4,000 crores, including EPC orders, providing strong execution visibility (Page 3). Key concall takeaways from…
19 Jul 2026
Indoco Remedies Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
Domestic business shows steady growth with top brands like Cyclopam growing over 20% in prescriptions. Key concall takeaways from Indoco Remedies's Q3 FY25…
19 Jul 2026
Suryoday Small Finance Bank Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
100 crores at the bank level. Key concall takeaways from Suryoday Small Finance Bank Ltd's Q3 FY26 earnings call — and how it ranks against sector peers.
19 Jul 2026
Iris Clothings Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Total income grew 12% in H1 FY’26 compared to previous year, indicating steady growth. Key concall takeaways from Iris Clothings Ltd's Q2 FY26 earnings call…
19 Jul 2026
Zim Laboratories Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
The company plans ~20% growth in ROW markets excluding Bangladesh, with stable business in Bangladesh. Key concall takeaways from Zim Laboratories Ltd's Q3…
19 Jul 2026
Prevest Denpro Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
The management emphasizes growth in both domestic and export markets, indicating healthy order inflows aligned with a 13% sales increase in FY25. Key concall…
19 Jul 2026
Beta Drugs Q2 FY26: Capex ₹9.45 Cr | Arthneeti
Q2 FY26
Beta Drugs plans to grow at a robust pace of 20-25% annually, as emphasized multiple times in the call. Key concall takeaways from Beta Drugs Ltd's Q2 FY26…
19 Jul 2026
BMW Industries Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
The tubes segment capacity has increased to 534,000 metric tons and will expand further to 700,000 with an INR 25 crore investment funded via internal…
19 Jul 2026
Synergy Green Industries Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
The company is preparing for a second phase of capacity increase to 100,000-120,000 tons progressively over FY26-27, involving a Capex of ₹400-500 crores (Page…
19 Jul 2026
Fino Payments Bank Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
EBITDA margin at highest level (15.4% in Q2), with disciplined cost control ongoing. Key concall takeaways from Fino Payments Bank Ltd's Q2 FY26 earnings call…
19 Jul 2026
United Foodbrands Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
International business is performing well, growing at around 30% year-on-year, providing a positive growth driver. Key concall takeaways from United Foodbrands…
19 Jul 2026
Solara Active Pharma Sciences Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Current capacity utilization in the growth API segment is about 70%. Key concall takeaways from Solara Active Pharma Sciences Ltd's Q3 FY26 earnings call — and…
19 Jul 2026